Identifying AANVS-derived Nanovesicles targeting genes in pancreatic cancer
We conducted the high throughput sequencing of RNA to compare the RNA expression pattern between no treated Highly Metastatic potential SUIT-2 cells and AANVS-derived Nanovesicles treated Highly Metastatic potential SUIT-2 cells. The total RNA was extracted from cells using TRIzol RNA isolation reagent. The transcriptome was evaluated by RNA sequencing which was performed at Novogene Bioinformatics Institute.